MEDI4736, an anti-PD-L1 antibody with modified Fc domain: Preclinical evaluation and early clinical results from a phase 1 study in patients with advanced solid tumors Meeting Abstract


Authors: Khleif, S.; Lutzky, J.; Segal, N.; Antonia, S.; Blake-Haskins, A.; Stewart, R.; Robbins, P.; Shalabi, A.; Ibrahim, R.; Wolchok, J.
Abstract Title: MEDI4736, an anti-PD-L1 antibody with modified Fc domain: Preclinical evaluation and early clinical results from a phase 1 study in patients with advanced solid tumors
Meeting Title: 17th European Cancer Conference (ECCO 17)
Journal Title: European Journal of Cancer
Volume: 49
Issue: Suppl. 2
Meeting Dates: 2013 Sep 27-Oct 1
Meeting Location: Amsterdam, Netherlands
ISSN: 0959-8049
Publisher: Elsevier Inc.  
Date Published: 2013-09-01
Start Page: S161
Language: English
ACCESSION: WOS:000326843601075
PROVIDER: wos
DOI: 10.1016/S0959-8049(13)70061-3
Notes: Meeting Abstract: 802 -- 17th ECCO / 38th ESMO / 32nd ESTRO European Cancer Congress on Reinforcing Multidisciplinarity -- SEP 27-OCT 01, 2013 -- Amsterdam, NETHERLANDS -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Jedd D Wolchok
    905 Wolchok
  2. Neil Howard Segal
    209 Segal